NICOLE DROBNER: Open Payments
NPI 1629748488 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 45 payments from 12 companies in 2025. Trend: 2023 $508 · 2024 $2,025 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $225 |
| Gilead Sciences, Inc. | 10 | $216 |
| Axsome Therapeutics, Inc. | 4 | $187 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Novo Nordisk Inc | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Organon LLC | 1 | $22 |
| PhotoniCare Inc | 1 | $20 |
Products named: Auvelity, REXULTI, Descovy, QULIPTA, VRAYLAR, Ozempic, UBRELVY, Symbravo.
Industry payments across NC — which companies pay providers there.
